Euroimmun AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Euroimmun AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10487
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Euroimmun AG (Euroimmun), a subsidiary of PerkinElmer Inc is a medical device company that provides automation products. The company offers products such as indications, technical IIFT products, and automations. Its indications comprise auto-immune encephalitis, auto antibodies, anti-NMDA receptors, antigen detection systems, E virus identification systems, allergology, and molecular diagnosis products. Euroimmun provides calprotectin ELISA used in the non invasive stool tests. The company offers services such as technical assistance, product management, and IFT image support services. It markets its products through a network of distributors in Brazil, India, Chile, Mexico, the US, Canada, Ecuador, South Africa, Argentina, Peru, the UK, Spain, Egypt, France, Russia, Australia, Latvia, the Czech Republic, and Sri Lanka. Euroimmun is headquartered in Lubeck, Germany.

Euroimmun AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Euroimmun AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Euroimmun AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Euroimmun AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Euroimmun AG, Medical Equipment, Deal Details 10
Partnerships 10
Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 10
Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 11
Acquisition 12
PerkinElmer Acquires Euroimmun for USD1.34 Billion 12
Euroimmun AG – Key Competitors 14
Euroimmun AG – Key Employees 15
Euroimmun AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Euroimmun AG, Medical Equipment, Key Facts 2
Euroimmun AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Euroimmun AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Euroimmun AG, Deals By Market, 2012 to YTD 2018 8
Euroimmun AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 10
Euroimmun Enters into Agreement with Angsana Molecular & Diagnostics 11
PerkinElmer Acquires Euroimmun for USD1.34 Billion 12
Euroimmun AG, Key Competitors 14
Euroimmun AG, Key Employees 15
Euroimmun AG, Other Locations 16
Euroimmun AG, Subsidiaries 16

List of Figures
Euroimmun AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Euroimmun AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Euroimmun AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Euroimmun AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Euroimmun AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Euroimmun AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • YTL Power International Berhad (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Berhad (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Wheaton Precious Metals Corp:企業の戦略・SWOT・財務情報
    Wheaton Precious Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Wheaton Precious Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Rhon-Klinikum AG (RHK):企業の財務・戦略的SWOT分析
    Summary Rhon-Klinikum AG (Rhon-Klinikum) is a healthcare service provider that offers medical care services. The center offers services such as nursing, physiotherapy, ergotherapy, logopaedics and dietician services. It provides medical assistance professions in the areas of functional diagnosis, la …
  • The Credit Mutuel-Cic Group:企業の戦略・SWOT・財務分析
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Concho Resources Inc.:戦略・SWOT・企業財務分析
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • DPL Inc:企業の戦略的SWOT分析
    DPL Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Sanford Health:医療機器:M&Aディール及び事業提携情報
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding d …
  • Diasome Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Diasome Pharmaceuticals Inc (Diasome) is a pharmaceutical company that focusses on clinical and commercial development of therapies for diabetes and obesity. The company offers products in the fields of cell receptor targeting, insulin replacement, and hepatic (liver) glucose metabolism. Its …
  • Terumo Cardiovascular Systems Corp:企業の戦略的SWOT分析
    Terumo Cardiovascular Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TesoRx Pharma LLC (TesoRx) is a pharmaceutical company that develops treatments to address unmet medical needs. The company’s product pipeline comprises TSD-001, TSD-005, TSX-011 and TSX-002. Its TSD-001is an intravesical paclitaxel for the treatment of non-muscle invasive bladder cancer. Te …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PCM Inc:企業の戦略・SWOT・財務情報
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Solvay Group:企業のM&A・事業提携・投資動向
    Solvay Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solvay Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Syncardia Systems LLC:医療機器:M&Aディール及び事業提携情報
    Summary Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients sufferin …
  • Ibersol S.G.P.S., S.A.:企業の戦略・SWOT・財務分析
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Egyptian Resorts Co
    Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report Summary Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ICON Plc (ICLR):企業の財務・戦略的SWOT分析
    ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆